
Thomas H. Kean
Thomas H. Kean (R-NJ) sold $15K-$50K of $SYK (Stryker Corporation Common Stock) on Jun 26, 2025, part of 4 transactions in this filing (2 buys, 2 sells).
HillSignal flagged 2 timing concerns on this filing — trades that line up closely with related legislative or contract activity.
Price Movement Since Trade
How the largest positions have moved from the trade date to the most recent close.
Suspicious Timing Detected
2 flagsThese flags identify timing coincidences between stock trades and legislative activity. They do not imply wrongdoing. Click any bill number or ticker to see the full analysis.
Share This Filing
All Transactions
| Type | Ticker | Asset | Amount | Trade Price | Current | Change | Date |
|---|---|---|---|---|---|---|---|
| BUY | $DHR | Danaher Corporation Common Stock | $1K-$15K | $204.72 | — | — | Jun 11, 2025 |
| BUY | $PLD | Prologis, Inc. Common Stock | $1K-$15K | $105.12 | — | — | Jun 30, 2025 |
| PARTIAL SELL | $SYK | Stryker Corporation Common Stock | $15K-$50K | $390.40 | — | — | Jun 26, 2025 |
| SELL | $WCC | WESCO International, Inc. Common Stock | $1K-$15K | $181.01 | — | — | Jun 23, 2025 |
Connected Legislative Activity
4 signalsThese bills and contracts share tickers or sectors with this filing's trades.
PRICE Act
The PRICE Act (HR4477) is an early-stage authorization bill establishing a grant program for manufactured housing community infrastructure improvements, but it authorizes no direct funding. No publicly-traded REIT is named or directly affected by the bill text. Market impact is negligible now; real analysis requires an appropriations bill.
CREATE JOBS Act
The CREATE JOBS Act (S.2056) proposes permanently reinstating 100% bonus depreciation for all U.S. businesses, a proven tax incentive reducing the after-tax cost of capital equipment by 21% in year one. At current market prices, capital-intensive companies like CAT ($810.05), DE ($560.02), FDX ($388.59), and AMZN ($263.04) have already shown strong 30-day momentum (CAT +21.37%, FDX +13.7%, AMZN +30.9%), reflecting broader economic expectations this tax policy reinforces. The bill is in early committee stage with legislative risk high, but identical House companion HR3967 improves odds of eventual enactment.
Medical Research for Our Troops Act
HR3906 (Medical Research for Our Troops Act) would restore $1.181B in military medical research funding, but the bill has been stalled in the House Appropriations Committee since June 2025 with zero legislative movement. Real market data shows healthcare stocks declining 3-8% over 30 days due to broader sector headwinds, not this bill. No actionable trade signal exists.
Critical Infrastructure Security Act
HR5236 (Critical Infrastructure Security Act) is an early-stage bill that expands CFIUS review to foreign investment in real estate tied to critical infrastructure, including intelligence community facilities, national laboratories, and drinking water infrastructure. This introduces new regulatory friction for foreign capital flows into real estate assets owned by REITs like Prologis, American Tower, Equinix, and Crown Castle. The bill has zero funding attached, is still in committee with only 3 cosponsors, and faces a long legislative path.
Other Filings by Thomas H. Kean
Free — no credit card
Get the next Kean trade the day it's disclosed
HillSignal tracks every Congressional stock filing and federal contract, scores its market impact with AI, and emails you the ones that matter — before they hit the news.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →
Data sourced from the U.S. House of Representatives Office of the Clerk Financial Disclosure system. Stock prices from Financial Modeling Prep. Suspicious timing flags identify coincidences between stock trades and legislative activity and do not imply any wrongdoing or illegal activity. This is not financial advice.